Atgam Solution For Injection 50Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Atgam: Solution for injection (50mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ANTI-THYMOCYTE IMMUNE GLOBULIN (an tee THI mo cite im MUNE GLOB yoo lin) weakens the body's immune system. This medicine is used to prevent and to treat kidney transplant rejection. It is also used to treat aplastic anemia.

In-Depth Information
Select a Medication

ATGAM 50mg/ml Solution for Injection

NDC: 000090926
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Kidney Transplant Rejection Prophylaxis, Kidney Transplant Rejection, Aplastic Anemia

Sometimes used for but not FDA approved for the following conditions:
Heart Transplant Rejection Prophylaxis, Heart Transplant Rejection, Myelodysplastic Syndrome (MDS), Stem Cell Transplant Preparation, Graft-versus-host Disease (GVHD) Prophylaxis, Graft-versus-host Disease (GVHD)

ATGAM 50mg/ml Solution for Injection

Reported Side Effects for ATGAM 50mg/ml Solution for Injection

Heart Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Convulsions Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Hole In Intestines Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Intestinal Bleeding Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Infusion-related Reactions Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Back Pain Incidence:
<10.0%*
Severity: MILD
Onset: DELAYED
Fluid In Lungs Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Chest Pain Incidence:
<10.0%*
Severity: MODERATE
Onset: EARLY
Inflamed Heart Muscle Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Muscle Pain Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
<5.0%*
Severity: MODERATE
Onset: RAPID
Back Pain Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Hemolysis Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Hemolytic Anemia Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Heart Failure Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Injection Site Reaction Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Tiredness Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Paresthesias Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Irritated Blood Vessels Incidence:
<5.0%*
Severity: MODERATE
Onset: RAPID
Weakness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Slow Heart Beat Incidence:
<5.0%*
Severity: SEVERE
Onset: RAPID
Severe Allergy Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Acute Lung Injury Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Eosinophilia Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Secondary Malignancy Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Post-transplant Lymphoproliferative Disorder (PTLD) Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: DELAYED
Joint Pain Incidence:
1.0-50.0%*
Severity: MILD
Onset: DELAYED
Low White Blood Cells Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Yeast Infection Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Feeling Sick Incidence:
4.0-14.0%*
Severity: MILD
Onset: EARLY
Serum Sickness Incidence:
5.0-85.0%*
Severity: SEVERE
Onset: DELAYED
Lightheadedness Incidence:
9.0-25.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
12.0%*
Severity: MILD
Onset: RAPID
Itching Incidence:
12.0%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
12.0-27.0%*
Severity: MILD
Onset: EARLY
High Potassium Level Incidence:
18.5-26.8%*
Severity: SEVERE
Onset: DELAYED
Shortness Of Breath Incidence:
19.8-28.0%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
23.5-26.8%*
Severity: MODERATE
Onset: RAPID
Infection Incidence:
23.5-30.5%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
>25.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
>25.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
>25.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
26.8-32.1%*
Severity: MILD
Onset: DELAYED
High Blood Pressure Incidence:
28.4-36.6%*
Severity: MODERATE
Onset: EARLY
Low White Blood Cell Counts Incidence:
29.6-57.3%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
34.6-40.2%*
Severity: MILD
Onset: EARLY
Low Platelet Count Incidence:
36.6-44.4%*
Severity: MODERATE
Onset: DELAYED
Chills Incidence:
43.2-57.3%*
Severity: MILD
Onset: RAPID
Fever Incidence:
63.0%*
Severity: MILD
Onset: EARLY
Antibody Formation Incidence:
68.0-78.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Atgam

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5